Angina News and Research

RSS

Angina is chest pain or discomfort that occurs when an area of your heart muscle doesn't get enough oxygen-rich blood. Angina may feel like pressure or squeezing in your chest. The pain also may occur in your shoulders, arms, neck, jaw, or back. It can feel like indigestion.

Rehabilitation significantly underused after heart attack and bypass surgery

Despite strong evidence that cardiac rehabilitation reduces disability and prolongs life, fewer than one in five people receive rehabilitation services after a heart attack or coronary bypass surgery, according to a Brandeis study in Circulation: Journal of the American Heart Association.

26 Sep 2007

Top five prescribed drugs

With a total nearly $5 billion, Lipitor, a cholesterol-reducing drug, ranked first in terms of total spending on prescription medicines by adults ages 18 to 64 in 2004, and another cholesterol-fighting drug, Zocor, ranked fourth at $2.3 billion, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

21 Sep 2007

Exercising in bad air could be a killer

A new study by British and Swedish researchers has found that air pollution could potentially harm the blood vessels and clotting abilities of people with heart disease.

14 Sep 2007

Platelets help white blood cells fight inflammation

Scientists have shown for the first time that platelets, the cells needed for blood clotting, help white blood cells called neutrophils fight inflammation.

13 Sep 2007

Effects of diesel exhaust on heart and blood vessel function

Air pollution could be putting patients with heart disease at risk by affecting blood vessels and clotting, researchers warn

13 Sep 2007

WHO warns about the impact of depression

A warning from the World Health Organistion (WHO) says that the impact of depression should not be underestimated.

9 Sep 2007

Gender (dis)advantages in cardiac remodeling

The topic of gender-related differences in cardiac care is an extremely complex one. Unfortunately women have been neglected in several fields of medicine for too long. I think that cardiology is only one of the many fields in the past where the male predominance was obvious.

3 Sep 2007

Lowering homocysteine with B-vitamins does not reduce cardiovascular risk

Secondary prevention with homocysteine-lowering B-vitamins does not reduce risk of death or major cardiovascular events, according to the WENBIT study.

3 Sep 2007

Do we harm women when we treat them in the same way as men?

Half of the female population in the western world die of cardiovascular disease. Neither the women themselves, nor society at large recognizes this fact. Maybe because of this, research on women with acute coronary syndromes is scarce and thus we lack knowledge about the best way to properly treat women with an acute myocardial infarction.

3 Sep 2007

Long term follow up of additional Swedish registry data does not indicate an increased

Four years of follow up including additional patients in the Swedish Coronary angiography and angioplasty registry (SCAAR) does no longer indicate any increased mortality in patients treated with drug eluting stents compared to patients treated with bare metal stents.

2 Sep 2007

Triage guidelines for emergency heart patients studied

Two new studies led by researchers at the University of Iowa and the Department of Veterans Affairs Iowa City Health Care System provide reassuring findings for patients evaluated in the emergency room for possible acute coronary syndrome (ACS) and the physicians who treat them.

30 Aug 2007

Diabetes increases risk of death for patients with acute coronary syndromes

Individuals with diabetes and acute coronary syndromes (ACS) such as a heart attack or unstable angina have an increased risk of death at 30 days and one year after ACS, compared with ACS patients without diabetes, according to a study in the August 15 issue of JAMA .

16 Aug 2007

Improving the quality of primary care could prevent 4 million hospitalizations each year

More than 4 million hospitalizations potentially could be prevented each year by improving the quality of primary care, enhancing patients' access to effective treatments, and getting more Americans to adopt healthy behaviors, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

13 Aug 2007

Actavis receives FDA OK for generic Inderal capsules

Actavis Group has announced that it has received approval from the U.S. Food & Drug Administration to market Propranolol Hydrochloride extended-release capsules. Distribution of the product will commence immediately.

13 Aug 2007

Court rules in favor of Sandoz on Toprol Xl patent

Sandoz was pleased to learn this week that the U.S. Court of Appeals in St. Louis has affirmed a summary judgment by U.S. District Judge Rodney Sippel invalidating patent protection on Toprol XL(R), a beta blocker used to treat angina, heart failure, and high blood pressure.

26 Jul 2007

Schering-Plough announces licensing of Acadesine

Schering-Plough Corporation has announced the worldwide licensing of acadesine, an investigational, potentially first-in-class adenosine regulating agent (ARA), from PeriCor Therapeutics, Inc., a privately held, specialty biopharmaceutical company.

20 Jul 2007

Caraco Pharmaceutical Labs announces FDA approval to market generic Tenormin

Caraco Pharmaceutical Laboratories has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Atenolol Tablets USP (atenolol).

12 Jul 2007

For older women HRT a risky option

According to an international study older women should not take Hormone Replacement Therapy (HRT).

12 Jul 2007

No benefit from HRT for older women

New evidence confirms that hormone replacement therapy (HRT) should not be prescribed to older women who are many years past the menopause. The treatment will not help prevent chronic conditions such as heart disease in these women.

11 Jul 2007

Ranbaxy receives approval to manufacture and market Amlodipine Besylate tablets

Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), has announced that RLL has received final approval from the U.S. Food and Drug Administration to manufacture and market Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).

11 Jul 2007